What areas does Institute for the Study of Aging Inc fund most directly?

Its current programs focus on Alzheimer’s disease and related dementias, especially drug discovery and development, biomarkers, diagnostics development, and prevention research. The active portfolio also includes neuroimaging, CSF biomarkers, digital biomarkers, neuroinflammation, proteostasis, senescence, and neuroprotection.

What is the typical grant size?

The distribution is highly uneven: the 25th percentile is $1,050, the median is $2,000, and the 75th percentile is $192,884. That pattern shows many smaller project awards alongside some much larger research grants.

Does the foundation accept unsolicited applications?

Yes for several active RFP-based programs, including Therapeutics Funding Programs, Biomarkers RFP, the FTD RFP, and the ADDF-Harrington Scholar Program. Some other initiatives, such as the Collaborative CNS Screening Initiative and the Diagnostics Accelerator portfolio, are not listed as accepting unsolicited applications.

Where does the foundation give most often?

New York is the top state by grant count, and 67% of grants go to recipients in New York. Recent grants include recipients in New York City as well as King of Prussia, Pennsylvania.

What kinds of funding mechanisms does it use?

The foundation uses project-based research funding, RFPs, and an annual prize. Its active programs include therapeutic and biomarker RFPs, diagnostics initiatives, and the Melvin R. Goodes Prize, which is an unrestricted monetary award of $150,000.

Institute for the Study of Aging

Name: Institute for the Study of Aging — grants, 990 financials & funding data
Creator: Kindora

Active

NEW YORK, NYWebsite2129018000EIN: 13-40241492 filings on record

About Institute for the Study of Aging

To rapidly accelerate the development of drugs to prevent, treat and cure Alzheimer’s disease through venture philanthropy investments in translational research and diagnostics.

Focus Areas

Alzheimer's disease and related dementiasDrug discovery and developmentBiomarkers (blood, CSF, neuroimaging, digital)Diagnostics development (Diagnostics Accelerator)Prevention researchNeuroinflammationProteostasisSenescenceNeuroprotectionDigital biomarkers

Who They Fund

people living with Alzheimer's disease and related dementiasolder adults

About Institute for the Study of Aging

Institute for the Study of Aging Inc centers its giving on Alzheimer’s drug discovery, with one recent grant accounting for almost the full amount of annual grants on file: $383,769 to the Alzheimer’s Drug Discovery Foundation in New York for research on Alzheimer’s drug discovery. That single award points to a highly specialized funder rather than a broad generalist grantmaker. The foundation’s active programs show a similar pattern of mission-focused research support: therapeutic funding streams, biomarker development, and diagnostics initiatives are all built around translational work that moves ideas toward clinical use. The foundation also made smaller awards in the same research lane, including $2,000 to the Association for Frontotemporal Degeneration in King of Prussia, Pennsylvania, and $100 to Historic House Trust in New York. Across its current programs, the emphasis stays on Alzheimer’s disease and related dementias, with support for drug development, biomarkers, diagnostics, and prevention research. The grants are project-based and tied to specific scientific aims rather than broad operating support, with a recurring emphasis on translational and therapeutic development.

What Institute for the Study of Aging Funds

The foundation’s cause areas cluster around translational Alzheimer’s research. In drug development, its Therapeutics Funding Programs support IND-enabling studies, early-stage clinical trials, and lead optimization for new therapies. Its Biomarkers RFP backs work to validate established and novel biomarkers, including PET, CSF, MRI, and EEG/MEG/TMS approaches, with a defined context of use and a path to commercialization. Diagnostics are another clear lane. The Diagnostics Accelerator portfolio supports early, accurate, and affordable Alzheimer’s diagnostics through peripheral biomarkers, digital biomarkers, and biobank sharing. Within that portfolio, the Digital Biomarkers RFP funds digital tools and apps, speech measures, and other digital signatures used in diagnosis, progression tracking, and clinical trial enrichment. Prevention research is also part of the program mix through the Therapeutics Funding Programs.

How Institute for the Study of Aging Gives

Typical grant size is sharply skewed: p25 is $1,050, median is $2,000, and p75 is $192,884. That spread reflects a mix of very small awards and a much larger research grant. The recent record also shows repeat support within the same year for New York recipients, while the broader program structure is project-based and research-specific rather than individual giving. The foundation uses request-for-proposals in several active programs, and multiple streams accept unsolicited applications. Other initiatives, including the Collaborative CNS Screening Initiative, are invitation-based or otherwise not open in the same way. Its active portfolio includes both grant programs and an annual prize, which is a different funding mechanism from project awards.

Financial Snapshot

Annual Giving

$386K

Total Assets

Total Revenue

$40K

Total Expenses

$180K

Typical Grant Size

Most grants fall between $1K and $193K, with a median of $2K.

25th Percentile

$1K

Median

$2K

75th Percentile

$193K

Geographic Reach

Regional2 states funded

About 67% of grants go to recipients in NY.

Funding intensity

Low

High

Headquarters

Unlock Deep Analysis

Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.

Get Started Free

See Similar Funders

Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.

Get Started Free

Want a Personalized Pitch for Institute for the Study of Aging?

Get Started Free View Pricing

Free plan available

No contracts

Cancel anytime

Recipient	Location	Amount	Year	Purpose
ALZHEIMER'S DRUG DISCOVERY FOUNDATION	NEW YORK, NY	$383,769	2023	RESEARCH ON ALZHEIMER'S DRUG DISCOVERY
ASSOCIATION FOR FRONTOTEMPORAL DEGENERATION	KING OF PRUSSIA, PA	$2,000	2023	RESEARCH ON ALZHEIMER'S DRUG DISCOVERY
HISTORIC HOUSE TRUST	NEW YORK, NY	$100	2023	RESEARCH ON ALZHEIMER'S DRUG DISCOVERY

Institute for the Study of Aging

About Institute for the Study of Aging

Focus Areas

Who They Fund

About Institute for the Study of Aging

What Institute for the Study of Aging Funds

How Institute for the Study of Aging Gives

Financial Snapshot

Typical Grant Size

Geographic Reach

Deep Analysis

Unlock Deep Analysis

Similar Funders

See Similar Funders

Want a Personalized Pitch for Institute for the Study of Aging?

Funding Style

Topics

Where Institute for the Study of Aging Makes Grants

Frequently Asked Questions About Institute for the Study of Aging

What areas does Institute for the Study of Aging Inc fund most directly?

What is the typical grant size?

Does the foundation accept unsolicited applications?

Where does the foundation give most often?

What kinds of funding mechanisms does it use?

Recent Grants

Open Grant Opportunities

Accelerating Drug Discovery for Frontotemporal Degeneration (FTD) RFP

Biomarkers RFP (ADDF Biomarkers Funding Opportunity)

SpeechDx

Diagnostics Accelerator (ADDF Diagnostics Accelerator initiative)

Institute for the Study of Aging

About Institute for the Study of Aging

Focus Areas

Who They Fund

About Institute for the Study of Aging

What Institute for the Study of Aging Funds

How Institute for the Study of Aging Gives

Financial Snapshot

Typical Grant Size

Geographic Reach

Unlock Deep Analysis

See Similar Funders

Want a Personalized Pitch for Institute for the Study of Aging?

The Grant Brief

Funding Style

Topics

Where Institute for the Study of Aging Makes Grants

Frequently Asked Questions About Institute for the Study of Aging

What areas does Institute for the Study of Aging Inc fund most directly?

What is the typical grant size?

Does the foundation accept unsolicited applications?

Where does the foundation give most often?

What kinds of funding mechanisms does it use?

Recent Grants

Open Grant Opportunities

Accelerating Drug Discovery for Frontotemporal Degeneration (FTD) RFP

Biomarkers RFP (ADDF Biomarkers Funding Opportunity)

SpeechDx

Diagnostics Accelerator (ADDF Diagnostics Accelerator initiative)